Anti-inflammatory effects of hydrophilic and lipophilic statins with hyaluronic acid against LPS-induced inflammation in porcine articular chondrocytes

Journal of Orthopaedic Research

Volumn 32, Issue 4, 2014, Pages 557-565

  Chang, Chih Hung ^a,b,c   Hsu, Yuan Ming ^a,b   Chen, Yu Chun ^a   Lin, Feng Huei ^d,e   Sadhasivam, Subramaniam ^d   Loo, Siow Tung ^e   Savitha, Sivasubramanian ^e,f  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b YUAN ZE UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f SREE SASTHA INSTITUTE OF ENGINEERING AND TECHNOLOGY   (India)

Author keywords

hyaluronic acid; inflammation; osteoarthritis; pravastatin; simvastatin

Indexed keywords

HYALURONIC ACID; INFLAMMATION; OSTEOARTHRITIS; PRAVASTATIN; SIMVASTATIN;

ANIMALS; CHONDROCYTES; COLLAGEN TYPE II; HYALURONIC ACID; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; IN SITU NICK-END LABELING; INJECTIONS, INTRA-ARTICULAR; LIPOPOLYSACCHARIDES; NF-KAPPA B P50 SUBUNIT; NITRIC OXIDE SYNTHASE TYPE II; OSTEOARTHRITIS; PRAVASTATIN; REAL-TIME POLYMERASE CHAIN REACTION; SIMVASTATIN; SWINE; VISCOSUPPLEMENTS;

EID: 84893871623     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22536     Document Type: Article

References (39)

1. Malfait AM, Liu RQ, Ijiri K, et al. 2002. Inhibition of ADAM-TS4 and ADAM-TS5 prevents aggrecan degradation in osteoarthritic cartilage. J Biol Chem 277: 22201-22208. (Pubitemid 34967185)
2. Sofat N, Ejindu V, Kiely P,. 2001. What makes osteoarthritis painful? The evidence for local and central pain processing. Rheumatology (Oxford) 50: 2157-2165.
3. Goldring MB, Otero M,. 2011. Inflammation in osteoarthritis. Curr Opin Rheumatol 23: 471-478.
4. Rogers J, Shepstone L, Dieppe P,. 2004. Is osteoarthritis a systemic disorder of bone ? Arthritis Rheum 50: 452-457.
5. Krasnokutsky S, Attur M, Palmer G, et al. 2008. Current concepts in the pathogenesis of osteoarthritis. Osteoarthritis Cartilage 16: S1-S3.
6. Smith MD, Triantafillou S, Parker A, et al. 1997. Synovial membrane inflammation and cytokine production in patients with early osteoarthritis. J Rheumatol 24: 365-371.et al. (Pubitemid 27104104)
7. Furst DE,. 1994. Are there differences among nonsteroidal antiinflammatory drugs? Comparing acetylated salicylates, nonacetylated salicylates, and nonacetylated nonsteroidal antiinflammatory drugs. Arthritis Rheum 37: 1-9. (Pubitemid 24027687)
8. Cannon GW, Caldwell JR, Holt P, et al. 2000. Rofecoxib, a specific inhibitor of cyclooxygenase 2, with clinical efficacy comparable with that of diclofenac sodium: results of a one-year, randomized, clinical trial in patients with osteoarthritis of the knee and hip. Rofecoxib Phase III Protocol 035 Study Group. Arthritis Rheum 43: 978-987. (Pubitemid 30368173)
9. Frampton JE, Keating GM,. 2007. Celecoxib: a review of its use in the management of arthritis and acute pain. Drugs 67: 2433-2472. (Pubitemid 350080285)
10. Fitzgerald GA,. 2004. Coxibs and cardiovascular disease. N Engl J Med 351: 1709-1711.
11. Leopold SS, Redd BB, Warme WJ, et al. 2003. Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial. J Bone Joint Surg Am 85-A: 1197-1203. (Pubitemid 36764925)
12. Strauss EJ, Hart JA, Miller MD, et al. 2009. Hyaluronic acid viscosupplementation and osteoarthritis: current uses and future directions. Am J Sports Med 37: 1636-1644.
13. Gigante A, Callegari L,. 2011. The role of intra-articular hyaluronan (Sinovial) in the treatment of osteoarthritis. Rheumatol Int 31: 427-444.
14. Friesen JA, Rodwell VW,. 2004. The 3-hydroxy-3-methylglutaryl coenzyme-A (HMG-CoA) reductases. Genome Biol 5: 248.1-248.7.
15. Abeles AM, Pillinger MH,. 2006. Statins as antiinflammatory and immunomodulatory agents: a future in rheumatologic therapy ? Arthritis Rheum 54: 393-407. (Pubitemid 43228614)
16. Yudoh K, Karasawa R,. 2010. Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis (OA). Aging (Albany NY) 2: 990-998.
17. Aktas E, Sener E, Gocun PU,. 2011. Mechanically induced experimental knee osteoarthritis benefits from anti-inflammatory and immunemodulatory properties of simvastatin via. Inhibition of matrix metalloproteinase-3. J Orthop Traumatol 12: 145-151.
18. Hatano H, Maruo A, Bolander ME, et al. 2003. Statin stimulates bone morphogenetic protein-2, aggrecan, and type 2 collagen gene expression and proteoglycan synthesis in rat chondrocytes. J Orthop Sci 8: 842-848. (Pubitemid 38017674)
19. Akasaki Y, Matsuda S, Nakayama K, et al. 2009. Mevastatin reduces cartilage degradation in rabbit experimental osteoarthritis through inhibition of synovial inflammation. Osteoarthritis Cartilage 17: 235-243.
20. Clockaerts S, Van Osch GJ, et al. 2012. Statin use is associated with reduced incidence and progression of knee osteoarthritis in the Rotterdam study. Ann Rheum Dis 71: 642-647.
21. Beattie MS, Lane NE, Hung YY, et al. 2005. Associationof statin use and development and progression of hip osteoarthritis in elderly women. J Rheumatol 32: 106-110. (Pubitemid 40092600)
22. Corsini A, Bellosta S, Baetta R, et al. 1999. New insights into the pharmacodynamic and pharmacokinetic properties of statins. Pharmacol Ther 84: 413-428.
23. Chang CH, Fang HW, Ho YC, et al. 2008. Chondrocyte acting as phagocyte to internalize polyethylene wear particles and leads to the elevations of osteoarthritis associated NO and PGE2. Biochem Biophys Res Commun 369: 884-888.
24. Aota Y, An HS, Imai Y, et al. 2006. Comparison of cellular response in bovine intervertebral disc cells and articular chondrocytes: effects of lipopolysaccharide on proteoglycan metabolism. Cell Tissue Res 326: 787-793. (Pubitemid 44786377)
25. Lin WY, Sadhasivam S, Lin FH,. 2009. The dose dependent effects of betulin on porcine chondrocytes. Process Biochem 44: 678-684.
26. Akmal M, Singh A, Anand A, et al. 2005. The effects of hyaluronic acid on articular chondrocytes. J Bone Joint Surg Br 87-B: 1143-1149. (Pubitemid 41131567)
27. Kawasaki K, Ochi M, Uchio Y, et al. 1999. Hyaluronic acid enhances proliferation and chondroitin sulphate synthesis in cultured chondrocytes embedded in collagen gels. J Cell Physiol 179: 142-148. (Pubitemid 29165142)
28. Kaufmann P, Török M, Zahno A, et al. 2006. Toxicity of statins on rat skeletal muscle mitochondria. Cell Mol Life Sci 63: 2415-2425. (Pubitemid 44653050)
29. Scher JU, Pillinger MH, Abramson SB,. 2007. Nitric oxide synthases and osteoarthritis. Curr Rheumatol Rep 9: 9-15. (Pubitemid 46806302)
30. Laufs U, La Fata V, Plutzky J, et al. 1998. Upregulation of endothelial nitric oxide synthase by HMG CoA reductase inhibitors. Circulation 97: 1129-1135. (Pubitemid 28152885)
31. Gertz K, Laufs U, Lindauer U, et al. 2003. Withdrawal of statin treatment abrogates stroke protection in mice. Stroke 34: 551-557. (Pubitemid 36206363)
32. Farlik M, Reutterer B, Schindler C, et al. 2010. Nonconventional initiation complex assembly by STAT and NF-kappaB transcription factors regulates nitric oxide synthase expression. Immunity 33: 25-34.
33. Ahmed S, Rahman A, Hasnain A, et al. 2003. Phenyl-N-tert-butylnitrone down-regulates interleukin-1β-stimulated matrix metalloproteinase-13 gene expression in human chondrocytes: suppression of c-Jun NH2 terminal kinase, p38-mitogen-activated protein kinase and activating protein-1. J Pharmacol Exp Ther 305: 981-988. (Pubitemid 36617975)
34. Mengshol JA, Vincenti MP, Coon CI, et al. 2000. Interleukin-1 induction of collagenase 3 (matrix metalloproteinase 13) gene expression in chondrocytes requires p38, c-Jun N-terminal kinase and nuclear factor kappaB. Differential regulation of collagenase 1 and collagenase 3. Arthritis Rheum 43: 801-811.
35. Zernia G, Huster D,. 2006. Collagen dynamics in articular cartilage under osmotic pressure. NMR Biomed 19: 1010-1019. (Pubitemid 46017722)
36. Chen LF, Greene WC,. 2004. Shaping the nuclear action of NF-kappaB. Nat Rev Mol Cell Biol 5: 392-401.
37. Singh R, Ahmed S, Islam N, et al. 2002. Epigallocatechin-3-gallate inhibits interleukin-1β-induced expression of nitric oxide synthase and production of nitric oxide in human chondrocytes: suppression of nuclear factor-κB (NF-κB/p65) activation by inhibiting IB-degradation. Arthritis Rheum 46: 2079-2086.
38. Chen CT, Burton-Wurster N, Borden C, et al. 2001. Chondrocyte necrosis and apoptosis in impact damaged articular cartilage. J Orthop Res 19: 703-711. (Pubitemid 32700988)
39. Barter MJ, Hui W, Lakey RL, et al. 2010. Lipophilic statins prevent matrix metalloproteinase mediated cartilage collagen breakdown by inhibiting protein geranylgeranylation. Ann Rheum Dis 69: 2189-2198.